药学干预在提升静脉输液使用合理率中的应用

Application of Pharmacy Intervention in Improving the Rational Use Rate of Intravenous Infusion

目的探讨药学干预在提升静脉输液使用合理率中的应用效果。方法选取在医院门诊2018年1月—2018年12月接受静脉输液治疗的急性患者98例作为研究对象,以随机数字表法进行分组,分别为观察组与对照组,每组患者各49例,对照组患者接受药学干预2小时,观察组患者接受全程药学干预,观察两组患者静脉输液的相关用药指标情况,观察两组患者静脉输液后的临床疗效情况,观察两组患者静脉输液后的不良反应发生情况。结果两组患者的输液时间合理、剂量合理指标对比差异无统计学意义(P>0.05);观察组患者溶媒合理指标、配伍合理指标均优于对照组(P<0.05),观察组患者静脉输液后的不良反应发生率低于对照组(P<0.05)。结论采用全程药学干预的静脉输液患者比接受2小时药学干预的静脉输液患者临床效果要显著,能够明显提高静脉输液的使用合理率,提高相关用药合理指标,降低患者不良反应的发生率。

Objective To explore the application effect of pharmaceutical intervention in improving the rational use rate of intravenous infusion. Methods From January 2018 to December 2018, a total of 98 acute patients who underwent intravenous infusion in our hospital were enrolled in the study. The patients were randomly assigned to the observation group and the control group. For example, patients in the control group received pharmacological intervention for 2 hours. Patients in the observation group received full-course pharmacy intervention. The drug-related indicators of intravenous infusion were observed in the two groups. The clinical efficacy of the two groups of patients after intravenous infusion was observed. The patients in the two groups were observed after intravenous infusion. The occurrence of adverse reactions. Results There was no significant difference between the two groups of patients with reasonable infusion time and reasonable dosage indicators(P>0.05);the observation group patients’ reasonable solvent indicators and reasonable compatibility indicators were better than those of the control group(P<0.05), and the observation group patients had intravenous infusion The incidence of adverse reactions afterwards was lower than that of the control group(P<0.05). Conclusion Patients with intravenous infusion with full-course pharmacy intervention have more clinical effects than those who receive 2-hour pharmacy intervention. They can significantly improve the rational use rate of intravenous infusion, improve the rationality of related medications, and reduce the incidence of adverse reactions.